Saturday, May 28, 2022
name of Prensa Latina
Bandera inglesa
English Edition
name of Prensa Latina



US health authorities recommend stopping Johnson & Johnson’s vaccine

US health authorities recommend stopping Johnson & Johnson’s vaccine

Washington, Apr 13 (Prensa Latina) US health authorities on Tuesday recommended stopping the use of the vaccine against Covid-19 developed by Johnson & Johnson after cases of blood clots were reported.
Share on facebook
Share on twitter
Share on whatsapp
Share on telegram
Share on email

According to the US CNN television channel on its website, six people were notified with blood coots after 6.8 million doses of the drug were applied in the US.

The six cases are female, aged from 18 to 48, and the symptoms occurred between six and 13 days after their vaccination.

Health authorities said they are holding the process to further review and evaluate the facts.

They also indicated that of ‘people who received the Johnson & Johnson vaccine, those who experienced a severe headache, abdominal discomfort, leg discomfort, or difficulty breathing within three weeks after vaccination should contact their healthcare provider.’

Experts called the event rare and advanced that the blood clotting may be related to Johnson & Johnson’s drug being an adenovirus vector vaccine, the same type as AstraZeneca’s, suspended in several European countries for the same reason.


name of Prensa Latina

| Text SMS to 8100 with content PL
Receive 4 mesages x 25 cup

© 2016-2021 Prensa Latina
Latin American News Agency

Radio – Publications  – Videos – News by the minute.
All Rigts Reserved.

St. E No 454 , Vedado,  Habana, Cuba.
Phones: (+53) 7 838 3496, (+53) 7 838 3497, (+53) 7 838 3498, (+53) 7 838 3499
Prensa Latina © 2021 .

Web Site developed by IT Division  Prensa Latina.